|
C20ORF4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.092340E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.693000E-01 |
| Normal-vs-Stage2 |
7.447200E-04 |
| Normal-vs-Stage3 |
8.632500E-04 |
| Normal-vs-Stage4 |
9.398900E-04 |
| Stage1-vs-Stage2 |
4.163800E-03 |
| Stage1-vs-Stage3 |
2.457400E-03 |
| Stage1-vs-Stage4 |
2.755900E-03 |
| Stage2-vs-Stage3 |
6.731400E-01 |
| Stage2-vs-Stage4 |
8.264000E-01 |
| Stage3-vs-Stage4 |
8.215000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.178700E-03 |
| Normal-vs-AfricanAmerican |
2.405600E-01 |
| Normal-vs-Asian |
3.516000E-01 |
| Caucasian-vs-AfricanAmerican |
3.871800E-01 |
| Caucasian-vs-Asian |
8.989600E-01 |
| AfricanAmerican-vs-Asian |
8.445400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.336940E-03 |
| Normal-vs-Female |
2.721600E-01 |
| Male-vs-Female |
3.075600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.388400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.413700E-02 |
| Normal-vs-Age(61-80Yrs) |
4.160700E-03 |
| Normal-vs-Age(81-100Yrs) |
3.401700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.507600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.169800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.030600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.067200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.543600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.712800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.779370E-01 |
| Normal-vs-Grade 2 |
2.102000E-01 |
| Normal-vs-Grade 3 |
8.601300E-04 |
| Normal-vs-Grade 4 |
2.05239999999662E-05 |
| Grade 1-vs-Grade 2 |
6.589500E-02 |
| Grade 1-vs-Grade 3 |
9.155400E-03 |
| Grade 1-vs-Grade 4 |
4.030800E-04 |
| Grade 2-vs-Grade 3 |
7.800200E-03 |
| Grade 2-vs-Grade 4 |
1.767190E-04 |
| Grade 3-vs-Grade 4 |
9.820000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.984400E-02 |
| Normal-vs-ccB subtype |
1.460020E-03 |
| ccA subtype-vs-ccB subtype |
2.730500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.762400E-03 |
| Normal-vs-N1 |
6.274400E-02 |
| N0-vs-N1 |
6.068200E-01 |
|
|
